Iron overload and public health;Surcharges en fer et santé publique

Bulletin de l'Academie Nationale de Medecine

Volumn 184, Issue 2, 2000, Pages 365-376

  Deugnier, Yves ^b   Moirand, Romain ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; MASS SCREENING; PUBLIC HEALTH; REVIEW;

HEMOCHROMATOSIS; HUMANS; IRON OVERLOAD; MASS SCREENING; PUBLIC HEALTH;

EID: 0346742414     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. CHARVET PROTAT S., YAOUANQ J., FLEURETTE F. - Devrions-nous dépister l'hémochromatose ? Une analyse critique de la littérature. Rev Epidémiol Santé Publique, 1997, 45, 315-327.
2. CULLEN L. M., SUMMERVILLE L., GLASSICK T.V., CRAWFORD D.H., POWELL L.W., JAZWINSKA E.C. - Neonatal screening for the hemochromatosis defect. Blood, 1997, 90, 4236-4237.
3. JOUANOLLE A.M., FERGELOT P., RAOUL M.L., GANDON G., ROUSSEY M., DEUGNIER Y., FEINGOLD J., LE GALL J.Y., DAVID V. - Prevalence of the C282Y mutation in Brittany. Ann Genet, 1998, 41, 195-198.
4. OLYNYK J.K., CULLEN D.G., AQUILIA S., ROSSI E., SUMMERVILLE L., POWELL L.W. - A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med, 1999, 341, 718-724.
5. BRISSOT P., MOIRAND R., GUYADER D., DEUGNIER Y. - Surcharges en fer. Encycl Méd Chir (Paris-France), Hépatologie, 1995, 7-200-A-10, 16 p.
6. NIEDERAU C., FISCHER R., SONNENBERG A., STREMMEL W., TRAMPISCH H.J., STROHMEYER G. -Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med, 1985, 313, 1256-1262.
7. ADAMS P.C., SPEECHLEY M., KERTESZ A.E. - Long-term survival analysis in hereditary hemochromatosis. Gastroenterology, 1991, 101, 368-372.
8. FARGION S., MANDELLI C., PIPERNO A., CESANA B., FRACANZANI A.L., FRAQUELLI M., BIANCHI P.A., FIORELLI G., CONTE D. - Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology, 1992, 15, 655-659.
9. NIEDERAU C., FISCHER R., PURSCHEL A., STREMMEL W., HAUSSINGER D., STROHMEYER G. -Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 1996, 110, 1107-1119.
10. PAWLOTSKY Y., LE DANTEC P., MOIRAND R., GUGGENBUHL P., JOUANOLLE A. M., CATHELINE M., MEADEB J., BRISSOT P., DEUGNIER Y., CHALES G. - Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis. Arthritis Rheum, 1999, 42, 799-806.
11. ADAMS P.C., SPEECHLEY M. - The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol, 1996, 23, 707-710.
12. DEUGNIER Y., GUYADER D., CRANTOCK L., LOPEZ J. M., TURLIN B., YAOUANQ J., JOUANOLLE H., CAMPION J. P., LAUNOIS B., HALLIDAY J.W. - Primary liver cancer in genetic hemochromatosis : a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology, 1993, 104, 228-234 Issn : 0016-5085.
13. WILSON J., JUNGER G. - The principles and practice of screening for disease. Public health Papers WHO, 1968, 34, 26-39.
14. Prevention and Control of Hemochromatosis : Improved Diagnosis - Report of a Joint WHO/Hemochromatosis Foundation/Canadian, French and UK Hemochromatosis Associations Meeting, St. Malo, France, 18 June 1997. Geneva, World Health Organization, 1998. Document WHO/HGN/HEMOCH/WG/98.3.1998.
15. ADAMS P., KERTESZ A., BARR R. - Population screening for hemochromatosis with the unbound iron binding capacity. Gastroenterology, 1998, 114, A1199.
16. BRISSOT P., MOIRAND R., JOUANOLLE A.M., GUYADER D., LEGALL J.Y., DEUGNIER Y., DAVID V. - A genotypic study of 217 unrelated probands diagnosed as «genetic hemochromatosis » on « classical » phenotypic criteria. J Hepatol, 1999, 30, 588-593.
17. DEUGNIER Y., MOIRAND R., GUYADER D., JOUANOLLE A., BRISSOT P. - Surcharges en fer et gène HFE. Gastroenterol Clin Biol, 1999, 23, 122-131.
18. ADAMS P.C., DEUGNIER Y., MOIRAND R., BRISSOT P. - The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology, 1997, 25, 162-166.
19. MOIRAND R., JOUANOLLE A.M., BRISSOT P., DEUGNIER Y. - Le dépistage de l'hémochromatose génétique. Hépato-Gastro, 1999, 6, 351-356.
20. SIMON M., BOUREL M., GENETET B., FAUCHET R. - Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med, 1977, 297, 1017-1021.
21. BULAJ Z., GRIFFEN L., JORDE L., EDWARDS C., KUSHNER J. - Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med, 1996, 335, 1799-1805.
22. MOIRAND R., JOUANOLLE A., BRISSOT P., LE GALL J.Y., DAVID V., DEUGNIER Y. - Phenotypic expression of the HFE mutations : a French study of 1 110 unrelated iron-overloaded patients and relatives. Gastroenterology, 1999, 116, 372-377.
23. ADAMS P.C., KERTESZ A., VALBERG L. - Screening for hemochromatosis in children of homozygotes : prevalence and cost - effectiveness. Hepatology, 1995, 22, 1720-1727.
24. ADAMS P.C. - Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet, 1998, 53, 176-178.
25. ADAMS P.C. - Population screening for hemochromatosis. Hepatology, 1999, 29, 1324-1327.
26. BRADLEY L.A., HADDOW J.E., PALOMAKI G.E. - Population screening for haemochromatosis. J Med Screen, 1996, 5, 178-184.
27. BUFFONE G.J., BECK J.R. - Cost-effectiveness analysis for evaluation of screening programs : hereditary hemochromatosis. Clin Chem, 1994, 40, 1631-1636.
28. PHATAK P.D., GUZMAN G., WOLL J.E., ROBESON A., PHELPS C.E. - Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med, 1994, 154, 769-776.
29. ADAMS P.C., GREGOR J.C., KERTESZ A.E., VALBERG L.S. - Screening blood donors for hereditary hemochromatosis : decision analysis model based on a 30-year database. Gastroenterology, 1995, 109, 177-188.
30. DEUGNIER Y., TURLIN B., LORÉAL O. - Iron and neoplasia. J Hepatol, 1998, 28, 21-25.
31. TURLIN B., JUGUET F., MOIRAND R., LE QUILLEUC D., LORÉAL O., CAMPION J. P., LAUNOIS B., RAMÉE M. P., BRISSOT P., DEUGNIER Y. - Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology, 1995, 22, 446-450.
32. SEMPOS C.T., LOOKER A.C., GILLUM R.F. - Iron and heart disease. Nut Rev, 1996, 54, 73-84.
33. DE VALK B., MARX J. J.M. - Iron, atherosclerosis, and ischemic heart disease. Arch Inter Med, 1999, 159, 1542-1548.
34. SULLIVAN J.L. - Iron and the genetics of cardiovascular disease. Circulation, 1999, 100, 1260-1263.
35. SULLIVAN J.L. - Iron and the sex difference in heart disease risk. Lancet, 1981, 1, 1293-1294.
36. ROEST M., VAN DER SCHOUW Y.T., DE VALK B., MARX J. J.M., TEMPELMAN M.J., DE GROOT P. G., SIXMA J.J., BANGA J.D. - Heterozygosity for the hereditary hemochromatosis gene is associated with cardiovascular mortality in women. Circulation, 1999, 100, 1268-1273.
37. MENDLER M., TURLIN B., MOIRAND R., JOUANOLLE A., SAPEY T., GUVADER D., LE GALL J., BRISSOT P., DAVID V., DEUGNIER Y. - Insulin resistance associated hepatic iron overload. Gastroenterology, 1999, 117, 1155-1163.
38. REAVEN G.M. - Role of insulin resistance in human disease. Diabetes, 1988, 37, 1595-1607.
39. ALBERTI K.G., ZIMMET P.Z. - Definition, diagnosis and classification of diabetes mellitus and its complications. Diabetes Med, 1998, 15, 539-553.
40. Consensus development conference on insulin resistance. - Diabetes Care, 1998, 21, 310-314.
41. MOIRAND R., MORTAJI A , LORÉAL O., PAILLARD F., BRISSOT P., DEUGNIER Y. - Liver iron overload with normal transferrin saturation : a new syndrome. Lancet, 1997, 349, 95-97.
42. TURLIN B., DEUGNIER Y. - Evaluation and interpretation of iron in the liver. Semin Diagn Pathol, 1998, 15, 237-245.
43. BECK-NIELSEN H. - General characteristics of the insulin resistance syndrome. Drugs, 1999, 58, 7-10.
44. DESPRÉS J.P., MARETTE A. - Relation of components of insulin resistance syndrome to coronary disease risk. Current Opin Lipidol, 1994, 5, 274-289.
45. ADAMI H.O., CHOW W.H., NYREN O., BERNE C., LINET M.S., EKBOM A., WOLK A., MCLAUGHLIN J.K., FRAUMENI J.F. - Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst, 1996, 88, 1472-1477.
46. WEIDERPASS E., GRIDLEY G., NYREN O., EKBOM A., ADAMI H.O. - Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst, 1997, 89, 600-601.
47. JAMES O.F.W., DAY C.P. - Non-alcoholic steatohepatitis (NASH) : A disease of emerging identity and importance. J Hepatol, 1998, 29, 495-501.
48. CALDWELL S.H., OELSNER D.H., IEZZONI J.C., HESPENHEIDE E.E., BATTLE E.H., DRISCOLL C.J. - Cryptogenic cirrhosis : Clinical characterization and risk factors for underlying disease. Hepatology, 1999, 29, 664-669.